Amaero Inc.

S-1/A amended

Price $5.15 · 3,883,496 shares · Gross proceeds $19,983,496

Amaero Inc. reported significant revenue growth from $1.3M in 2024 to $6.3M in 2025, driven by scaled-up Tennessee manufacturing operations and customer qualification programs. For the six months ended June 2026, revenue surged to $7.4M, reflecting expanded production capacity and new customer contracts. However, the company faces material risks including customer concentration, liquidity constraints from dual listings, and uncertainties around its corporate redomicile. Gross losses persisted due to high fixed production costs, while operating expenses increased from $10.5M to $13.4M. The filing also highlights ongoing challenges with internal controls and reliance on key customers, with net losses worsening to $18.4M in 2025 and $13.4M in H1 2026.

CERT inactive

8-A12B effective

S-1/A amended

Price $7.06 · 7,456,500 shares

Amaero Inc. filed an S-1/A registration statement for its U.S. IPO, offering 7,456,500 shares of common stock with an underwriters' option to purchase an additional 1,118,475 shares. The offering aims to raise $46.1 million (net proceeds) to fund capital equipment purchases, working capital, and general corporate purposes. The company completed its redomicile from Australia to Delaware in June 2026, becoming a U.S. entity, and is transitioning from its Australian CDI structure. The filing highlights risks related to liquidity, financial controls, and compliance with ASX and SEC regulations.

S-1/A amended

Price $7.06 · 7,456,500 shares

Amaero Inc. has completed its redomiciliation from Australia to Delaware, transitioning from Amaero Ltd. The S-1/A filing details a U.S. IPO offering 7,456,500 common shares, with an underwriters' option for 1,118,475 additional shares. Net proceeds of ~$46.1M (or $53.4M if the option is exercised) will fund capital equipment purchases, general corporate purposes, and potential acquisitions. The filing highlights risks from dual listing on ASX/Nasdaq, liquidity constraints, internal control weaknesses, and reliance on the offering for continued operations. The company remains an emerging growth company with reduced disclosure requirements.

S-1 filed

Amaero Inc. is conducting an IPO to raise capital for expanding manufacturing capacity, developing new products, and advancing its PM-HIP business. The filing highlights risks related to market uncertainties, regulatory compliance, and execution of growth strategies. The company plans to use proceeds for capital equipment, R&D, and general corporate purposes, while emphasizing its redomiciliation benefits and dual listing on Nasdaq and ASX. Forward-looking statements caution about potential discrepancies between projections and actual outcomes.

DRS/A amended

Amaero Inc. reported a significant increase in revenue to $6.3 million in 2025 from $1.3 million in 2024, driven by the scaling of its Tennessee manufacturing operations. However, the company posted a net loss of $18.4 million in 2025 compared to $12.7 million in 2024, with gross losses widening due to expanded production costs. Adjusted EBITDA declined to $(15.0 million) from $(10.4 million), reflecting ongoing operational challenges. The filing emphasizes non-GAAP metrics like Adjusted EBITDA while highlighting risks related to customer concentration and the costs of becoming a public company.

CONFIDENTIAL-S1 filed

Amaero became a new in-window confidential-filing lead on July 15, 2026 when it explicitly reported a confidential SEC draft Form S-1 submission for a proposed U.S. IPO. Supporting context from February and June 2026 shows the company had re-domiciled to the U.S. and was publicly signaling a late-2026 to early-2027 U.S. listing window.

DRS filed

Amaero Inc. reports a significant increase in revenue from $1.3 million in 2024 to $6.3 million in 2025, driven by the ramp-up of Tennessee manufacturing operations and customer qualification programs. However, the company posted a net loss of $18.4 million in 2025 compared to $12.7 million in 2024, with adjusted EBITDA worsening to -$15.0 million from -$10.4 million. Key financial metrics show growing costs, including a 176% increase in cost of revenue to $11.5 million, while operational losses expanded by 36%. The filing highlights risks including customer concentration, reliance on key contracts, and challenges in scaling production.